Well Referenced

Tag: bone age

Growth response to growth hormone-releasing hormone(1-29)-NH2 compared with growth hormone

This study compared the effectiveness of growth hormone-releasing hormone (GHRH(1-29)-NH₂) with standard growth hormone (GH) therapy in promoting growth in children with hypothalamic growth hormone deficiency (GHD). High-dose GHRH(1-29)-NH₂ significantly increased height velocity, comparable to GH treatment, but had no effect on bone age development. GHRH(1-29)-NH₂ did not induce GH

Read More »
June 26, 2025 No Comments

Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group

This randomized controlled trial evaluated the effectiveness of daily subcutaneous administration of growth hormone-releasing hormone (GHRH(1-29)) in 110 children with growth hormone deficiency. Over a 12-month period, the treatment significantly increased height velocity, with an average increase to 8.0 cm/year at 6 months and 7.2 cm/year at 12 months. At

Read More »
June 26, 2025 No Comments